SPARC, an upstream regulator of connective tissue growth factor in response to transforming growth factor β stimulation

Arthritis and Rheumatism

Volumn 54, Issue 12, 2006, Pages 3885-3889

  Zhou, X D ^a   Xiong, M M ^a   Tan, F K ^a   Guo, X J ^a   Arnett, F C ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; OSTEONECTIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; COL11A1 GENE; COL1A2 GENE; COL3A1 GENE; COMPARATIVE STUDY; CONTROLLED STUDY; CTGF GENE; EXTRACELLULAR MATRIX; FIBROBLAST; GENE; GENE OVEREXPRESSION; GENETIC MODEL; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NEGATIVE FEEDBACK; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY; SPARC GENE; TIMP3 GENE;

CELLS, CULTURED; COLLAGEN; DERMIS; EXTRACELLULAR MATRIX; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OSTEONECTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33845672611     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22249     Document Type: Article

References (13)

1. Brekken RA, Sage EH. SPARC, a matricellular protein: at the crossroads of cell-matrix. Matrix Biol 2001;19:816-27.
2. Zhou X, Tan FK, Reveille JD, Wallis D, Milewicz DM, Ahn C, et al. Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma. Arthritis Rheum 2002;46:2990-9.
3. Kuhn C, Mason RJ. Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis. Am J Pathol 1995;147: 1759-69.
4. Frizell E, Liu SL, Abraham A, Ozaki I, Eghbali M, Sage EH, et al. Expression of SPARC in normal and fibrotic livers. Hepatology 1995;21:847-54.
5. Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001;21:1998-2003.
6. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994;331:1286-92.
7. Grotendorst GR. Connective tissue growth factor: a mediator of TGF-β action on fibroblasts. Cytokine Growth Factor Rev 1997; 8:171-9.
8. Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H, Huang X, et al. Connective tissue growth factor mediates transforming growth factor β-induced collagen synthesis: down-regulation by cAMP. FASEB J 1999;13:1774-86.
9. Zhou X, Tan FK, Quo X, Wallis D, Milewicz DM, Xue S, et al. Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor β1 in cultured normal human fibroblasts. Arthritis Rheum 2005;52:257-61.
10. Zhou XD, Tan FK, Guo X, Arnett FC. Attenuation of collagen synthesis with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma. Arthritis Rheum 2006;54:2626-31.
11. Xiong M, Feghali-Bostwick CA, Arnett FC, Zhou X. A systems biology approach to genetic studies of complex diseases. FEBS Lett 2005;579:5325-32.
12. Xiong M, Li J, Fang X. Identification of genetic networks. Genetics 2004;166:1037-52.
13. Bollen KA. Structural equations with latent variables. New York: John Wiley & Sons; 1989.